Brendan Wood International
TopGun® Press

Brendan Wood International Investor Conviction Intel – Global Healthcare – November 2023

November 22nd, 2023 by TopGun Press

New York, NY, November 22nd, 2023 (TopGun Press)

Below are some of the most topical Healthcare stocks in the BWI Shareholder Confidence Index based on our daily chats with global investors. Below are links to the Investor Conviction Intel on Eli Lilly and Novo Nordisk.

Eli Lilly and Novo Nordisk: Both Eli Lilly and Novo Nordisk continue to occupy the lion’s share of mind space with investors in Biotech and Pharmaceuticals. Eli Lilly garners slightly better ownership penetration thus far in 4Q, with more increasing confidence holders and less downsizers, than Novo Nordisk, making Lilly’s current ownership conviction stronger. Novo Nordisk continues to lead the way on BWI’s Investment Quality Index, rating highest amongst the big cap Biotech & Pharmaceuticals names but Eli Lilly is closing the gap. (CLICK HERE FOR THE INVESTOR CONVICTION INTEL ON ELI LILLY AND CLICK HERE FOR THE INVESTOR CONVICTION INTEL ON NOVO NORDISK)

Vertex Pharmaceuticals: CEO, Reshma Kewalramani, is starting to get more credit from investors after what they refer to as a “rocky” start and facing reluctance. However, investors remain somewhat cautious when it comes to Vertex’s work on pain and diabetes. Investors want to see more of the Bench and want Vertex to use some of their cash. Investor confidence in Vertex’s Short and Long Term Growth potential remains one of the highest amongst the big cap Biotech & Pharmaceuticals companies on BWI’s Index but, confidence in Short Term Growth Potential has trended slightly lower thus far in 4Q 2023.

Thermo Fisher Scientific: Investor ownership conviction for the year ahead in all the Healthcare micro sectors (Biotech, Healthcare Services, Medical Technology and Pharmaceuticals) declined in 3Q. Although the Medical Technology space remains relatively well owned, it saw the most significant decrease in average ownership penetration. China concerns and bioprocess destocking are top of mind with investors. Thermo Fisher has typically been a name that investors buy, put away and have confidence in management. It remains the most well owned of the Medical Technology names on BWI’s Index however ownership penetration declined through 3Q and expectations for the near term are tempered. Investor confidence in the Short Term Growth Potential declined for the second quarter in a row. Confidence in management, Marc Casper in particular, remains high but as one investor put it, “I can’t shut my eyes and be comfortable.”

Largest Index Score Increases (YE 4Q2023 at Nov. 20 vs. YE 3Q2023):

Fresenius SE +3.6%
Boston Scientific Corp. +2.6%
Eli Lilly and Company +1.8%


Click here for the Investor Conviction Intel for Healthcare September 2023


Brendan Wood International (BWI) serves a dual clientele of world leading investors and their corporate investment targets as well as broker dealers who provide research, sales and trading services to the investment community. Big cap companies looking for comprehensive investor confidence data on their organizations are likely to discover that Brendan Wood partners consult with their investors non stop year round. Investors depend on BWI to quantify the demand side of the investment industry across 1400 names worldwide, including the name by name research sales and trading professionals who influence investor demand.

About Brendan Wood International:

Brendan Wood International (BWI), formed in 1970, is a private advisory group which originates performance investigation programs in the capital markets. Brendan Wood Partners debrief large institutional investors worldwide on a daily basis. There are 2000+ live consultations with professionals overseeing +/- $55 trillion invested in the +/- 1400 big cap companies on the BWI Index. Relying on its real time performance intelligence, BWI advises public companies, institutional and activist investors, investment banks and broker dealers on strategy, performance and recruitment of TopGun talent. The firm’s partners have formally presented at 1000+ C level strategy meetings and corporate off-sites in fifty cities. Brendan Wood founded the exclusive TopGun Club, a performance based institution.


We wish to emphasize that all reports, evaluations and assessments contained herein, represent Brendan Wood International’s subjective judgment and opinions, based on our years of experience and on information obtained by us in the course of our research. Much of the factual information contained in the reports has been obtained by us from third parties on whose responses we have relied in good faith, independent verification by Brendan Wood International being, under the circumstances, impossible. While we believe that you will find our reports to be an invaluable tool in formulating your own strategies and judgments, the foregoing should be borne in mind. This report is not meant as investment advice and should not be interpreted as advising on the value of a company’s securities, the advisability of investing in, purchasing or selling any company’s securities or any other conclusion relating to investment/divestiture of a company’s securities. Finally, this report is not intended as an offer or solicitation for the purchase or sale of any company’s securities.


Related Links:

Amanda Knott
Managing Director
Brendan Wood International
+1 416 924 8110

Jordan Novak
Managing Partner
Brendan Wood International
+1 416 924 8110

Posted in Press Releases |

You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.

In the Press

Recent Stories

TopGun® TV


© Brendan Wood Shareholder Confidence Index  |  Brendan Wood International  |  Powered by IWD Canada